Hypoplastic Left Heart Syndrome: Current Considerations and Expectations
Top Cited Papers
- 3 January 2012
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 59 (1), S1-S42
- https://doi.org/10.1016/j.jacc.2011.09.022
Abstract
No abstract availableKeywords
Funding Information
- Medtronic
- Pfizer
- GlaxoSmithKline
This publication has 463 references indexed in Scilit:
- Evaluating Failing Fontans for Heart Transplantation: Predictors of DeathThe Annals of Thoracic Surgery, 2009
- Comparison of Echocardiographic and Cardiac Magnetic Resonance Imaging Measurements of Functional Single Ventricular Volumes, Mass, and Ejection Fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)The American Journal of Cardiology, 2009
- Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricleAmerican Heart Journal, 2009
- Endovascular stents for relief of cyanosis in single‐ventricle patients with shunt or conduit‐dependent pulmonary blood flowCatheterization and Cardiovascular Interventions, 2006
- Fetal atrioventricular valve insufficiency associated with nonimmune hydrops: a two-dimensional echocardiographic and pulsed Doppler ultrasound study.Circulation, 1985
- Physiologic Repair of Aortic Atresia–Hypoplastic Left Heart SyndromeThe New England Journal of Medicine, 1983
- Rest and exercise hemodynamics after the Fontan procedure.Circulation, 1982
- Administration of prostaglandin E1 in neonates with critical congenital cardiac defectsThe Journal of Pediatrics, 1978
- Models of congenital heart disease in fetal lambs.Circulation, 1978
- Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation, 1977